Page 82 - Read Online
P. 82

Page 6 of 8                                                 Di Pumpo et al. Vessel Plus 2018;2:41  I  http://dx.doi.org/10.20517/2574-1209.2018.38

               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Approved by the institution where the work was carried out.

               Copyright
               © The Author(s) 2018.



               REFERENCES

               1.   Landoni G, Fochi O, Torri G. Cardiac protection by volatile anaesthetics: a review. Curr Vasc Pharmacol 2008;6:108-11.
               2.   Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation
                   1986;74:1124-36.
               3.   Warltier DC, al-Wathiqui MH, Kampine JP, Schmeling WT. Recovery of contractile function of stunned myocardium in chronically in-
                   strumented dogs is enhanced by halothane or isoflurane. Anesthesiology 1988;69:552-65.
               4.   Cason BA, Gamperl AK, Slocum RE, Hickey RF. Anesthetic-induced preconditioning: previous administration of isoflurane decreases
                   myocardial infarct size in rabbits. Anesthesiology 1997;87:1182-90.
               5.   Chiari P, Bouvet F, Piriou V. Anaesthetic-induced myocardial preconditioning: fundamental basis and clinical implications. Ann Fr
                   Anesth Reanim 2005;24:383-96. (in French)
               6.   Varadarajan SG, An J, Novalija E, Stowe DF. Sevoflurane before or after ischemia improves contractile and metabolic function while
                   reducing myoplasmic Ca(2+) loading in intact hearts. Anesthesiology 2002;96:125-33.
               7.   Ross S, Foëx P. Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. Br J Anaesth 1999;82:622-32.
               8.   Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC. Sevoflurane reduces myocardial infarct size and decreases the time thresh-
                   old for ischemic preconditioning in dogs. Anesthesiology 1999;91:1437-46.
               9.   Preckel B, Schlack W, Comfère T, Obal D, Barthel H, et al. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion
                   injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998;81:905-12.
               10.  Landoni G, Augoustides JG, Guarracino F, Santini F, Ponschab M, et al. Mortality reduction in cardiac anesthesia and intensive care:
                   results of the first International Consensus Conference. Acta Anaesthesiol Scand 2011;55:259-66.
               11.  Muntean DM, Ordodi V, Ferrera R, Angoulvant D. Volatile anaesthetics and cardioprotection: lessons from animal studies. Fundam Clin
                   Pharmacol 2013;27:21-34.
               12.  Riess ML, Kevin LG, Camara AK, Heisner JS, Stowe DF. Dual exposure to sevoflurane improves anesthetic preconditioning in intact
                   hearts. Anesthesiology 2004;100:569-74.
               13.  Ludwig LM, Patel HH, Gross GJ, Kersten JR, Pagel PS, et al. Morphine enhances pharmacological preconditioning by isoflurane: role
                   of mitochondrial K(ATP) channels and opioid receptors. Anesthesiology 2003;98:705-11.
               14.  Kato R, Foëx P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J
                   Anesth 2002;49:777-91.
               15.  Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, et al. Is isoflurane-induced preconditioning dose related? Anesthesiology
                   2002;96:675-80.
               16.  Lange M, Redel A, Lotz C, Smul TM, Blomeyer C, et al. Desflurane-induced postconditioning is mediated by beta-adrenergic signal-
                   ling: role of beta 1- and beta 2-adrenergic receptors, protein kinase A, and calcium/calmodulin-dependent protein kinase II. Anesthesiol-
                   ogy 2009;110:516-28.
               17.  Halestrap AP, Clarke SJ, Javadov S. Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for car-
                   dioprotection. Cardiovasc Res 2004;61:372-85.
               18.  Di Lisa F, Menabò R, Canton M, Barile M, Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of
                   mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol
                   Chem 2001;276:2571-5.
               19.  Landoni G, Lopez-Delgado JC, Sartini C, Tamà S, Zangrillo A. Halogenated agents and cardiovascular surgery: has mortality really de-
                   creased? Curr Vasc Pharmacol 2018;16:336-43.
   77   78   79   80   81   82   83   84   85   86   87